SOPHARMA (SPH): SOPHARMA AD (133/2024) Correction of report 131/2024 - raport 133/2024
Raport ESPI
Report no 133/2024
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
Correction of report 131/2024
